Apollon Wealth Management’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,697
Closed -$274K 1238
2024
Q3
$274K Hold
14,697
0.01% 937
2024
Q2
$257K Hold
14,697
0.01% 915
2024
Q1
$248K Hold
14,697
0.01% 944
2023
Q4
$244K Buy
14,697
+3,607
+33% +$55.4K 0.01% 919
2023
Q3
$172K Buy
11,090
+946
+9% +$15.8K 0.01% 845
2023
Q2
$173K Hold
10,144
0.01% 882
2023
Q1
$179K Hold
10,144
0.01% 801
2022
Q4
$183K Hold
10,144
0.01% 787
2022
Q3
$175K Hold
10,144
0.01% 732
2022
Q2
$190K Hold
10,144
0.02% 685
2022
Q1
$211K Hold
10,144
0.02% 678
2021
Q4
$241K Buy
+10,144
New +$253K 0.02% 646

Other funds holding HQH

Apollon Wealth Management's HQH Position: Q4 2024 in Review

Apollon Wealth Management sold out of abrdn Healthcare Investors (HQH) in Q4 2024, closing a stake of 14,697 shares — an estimated $274K sold.

Apollon Wealth Management first reported a position in HQH in Q4 2021 and held it in 12 quarters. The position peaked at $274K in Q3 2024. 120 funds tracked by Wall St. Rank hold HQH as of Q4 2024.

  • Apollon Wealth Management reported no remaining abrdn Healthcare Investors position as of Q4 2024 after selling out during the quarter.
  • Apollon Wealth Management sold 14,697 abrdn Healthcare Investors shares in Q4 2024, an estimated $274K.
  • Apollon Wealth Management first reported a position in abrdn Healthcare Investors in Q4 2021 and held it in 12 quarters.
  • Apollon Wealth Management's abrdn Healthcare Investors position peaked at $274K in Q3 2024.
  • 120 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q4 2024.

Based on Apollon Wealth Management's 13F filing for Q4 2024, filed 28 Jan 2025.